Monogram Orthopaedics (Monogram Orthopaedics) Debt-to-Equity : 0.04 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Monogram Orthopaedics Debt-to-Equity?

Monogram Orthopaedics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.13 Mil. Monogram Orthopaedics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.36 Mil. Monogram Orthopaedics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $13.40 Mil. Monogram Orthopaedics's debt to equity for the quarter that ended in Dec. 2023 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Monogram Orthopaedics's Debt-to-Equity or its related term are showing as below:

MGRM' s Debt-to-Equity Range Over the Past 10 Years
Min: -7.72 Med: 0.04 Max: 0.15
Current: 0.04

During the past 7 years, the highest Debt-to-Equity Ratio of Monogram Orthopaedics was 0.15. The lowest was -7.72. And the median was 0.04.

MGRM's Debt-to-Equity is ranked better than
83.64% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs MGRM: 0.04

Monogram Orthopaedics Debt-to-Equity Historical Data

The historical data trend for Monogram Orthopaedics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Orthopaedics Debt-to-Equity Chart

Monogram Orthopaedics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-7.72

0.04

0.06

0.15

0.04

Monogram Orthopaedics Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial											0.15	0.72	0.05	0.04	0.04

Competitive Comparison of Monogram Orthopaedics's Debt-to-Equity

For the Medical Devices subindustry, Monogram Orthopaedics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monogram Orthopaedics's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monogram Orthopaedics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Monogram Orthopaedics's Debt-to-Equity falls into.

Monogram Orthopaedics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Monogram Orthopaedics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.128	+	0.364)	/	13.397
	=	0.04

Monogram Orthopaedics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.128	+	0.364)	/	13.397
	=	0.04

Monogram Orthopaedics (NAS:MGRM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Monogram Orthopaedics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Monogram Orthopaedics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Monogram Orthopaedics (Monogram Orthopaedics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Orthopaedics Inc (NAS:MGRM) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

J7J:Germany

Address

3913 Todd Lane, Suite 307, Austin, TX, USA, 78744

Website

https://www.monogramorthopedics.com

Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Executives

Paul H Riss	director
Noel Knape	officer: Chief Financial Officer	3913 TODD LANE, AUSTIN TX 78744
Benjamin Sexson	director, 10 percent owner, officer: Chief Executive Officer	3913 TODD LANE, AUSTIN TX 78744
Noel Goddard	director	3913 TODD LANE, AUSTIN TX 78744
Kamran Shamaei	officer: Chief Technology Officer	3913 TODD LANE, AUSTIN TX 78744
Douglas Unis	director	3913 TODD LANE, AUSTIN TX 78744